title: Reduced glutathione protect cells from ouabain toxicity.
abstract: It is widely accepted that a prolonged ouabain blockade of the Na(+),K(+)-ATPase makes cells detach from each other and from the substrate, leading to their death and that cellular resistance to ouabain is due to the presence of isoforms of Na(+),K(+)-ATPase with low affinity to this glycoside. In the present work the effect of reduced glutathione in the response of two types of renal cells to ouabain: MDCK, a ouabain-sensitive cell line and Ma104, a ouabain-resistant one, was studied. Glutathione protected MDCK cells from ouabain toxicity and inhibition of glutathione synthesis by L-buthionine-S,R-sulfoximine sensitized Ma104 cells to ouabain. As glutathione is involved with multidrug resistance (MDR) in cells expressing the multidrug resistance-related protein MRP1 and as Ma104 cells have a MDR phenotype, it was investigated whether Ma104 cells express this protein. The expression of the MRP1-mRNA in Ma104 cells was detected by reverse transcriptase-polymerase chain reaction and ribonuclease protection assay, and the protein was detected by Western blotting and immunofluorescence. Treatment of Ma104 cells with ouabain increased MRP1-mRNA expression and altered the localization of MRP1 in these cells. Our results suggest that some cells may have mechanisms to protect themselves from ouabain toxicity and that MRP1 may have a role in controlling the toxic effects of ouabain.
authors: Instituto de Biofisica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, RJ, Brazil. capella@bioqmed.ufrj.br
authors: L S
authors: LS
authors: Capella
authors: M
authors: M
authors: Gefé
authors: E F
authors: EF
authors: Silva
authors: M M
authors: MM
authors: Morales
authors: O
authors: O
authors: Affonso-Mitidieri
authors: A G
authors: AG
authors: Lopes
authors: V M
authors: VM
authors: Rumjanek
authors: M A
authors: MA
authors: Capella
mesh_terms: D018528:ATP-Binding Cassette Transporters / Q000032:analysis* / Q000235:genetics; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D015153:Blotting, Western; D019328:Buthionine Sulfoximine / Q000494:pharmacology; D002374:Catalase / Q000494:pharmacology; D002460:Cell Line / Q000187:drug effects; D018432:Drug Resistance, Multiple / Q000235:genetics; D005455:Fluorescent Antibody Technique; D005786:Gene Expression Regulation / Q000187:drug effects*; D005978:Glutathione / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D027425:ATP-Binding Cassette, Sub-Family C Proteins; D010042:Ouabain / Q000037:antagonists & inhibitors / Q000633:toxicity*; D010641:Phenotype; D012333:RNA, Messenger / Q000032:analysis; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013482:Superoxide Dismutase / Q000494:pharmacology
chemical_list: D018528:ATP-Binding Cassette Transporters; D000975:Antioxidants; D019328:Buthionine Sulfoximine; D002374:Catalase; D005978:Glutathione; D027425:ATP-Binding Cassette, Sub-Family C Proteins; D010042:Ouabain; D012333:RNA, Messenger; D013482:Superoxide Dismutase